| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturers
|
Dellepiane, Nora
|
|
|
6 |
C |
p.
|
article
|
| 2 |
Editorial Board
|
|
|
|
6 |
C |
p.
|
article
|
| 3 |
Field safety study of VANGUARD®crLyme: A vaccine for the prevention of Lyme disease in dogs
|
Marconi, Richard T.
|
|
|
6 |
C |
p.
|
article
|
| 4 |
How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making
|
Botwright, Siobhan
|
|
|
6 |
C |
p.
|
article
|
| 5 |
Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial
|
Capeding, Maria Rosario
|
|
|
6 |
C |
p.
|
article
|
| 6 |
Safety and immunogenicity of the Rift Valley fever arMP-12 ΔNSm21/384 candidate vaccine in pregnant ewes
|
Boumart, Z.
|
|
|
6 |
C |
p.
|
article
|
| 7 |
The economic burden of measles in children under five in Uganda
|
De Broucker, Gatien
|
|
|
6 |
C |
p.
|
article
|
| 8 |
VANGUARD®crLyme: A next generation Lyme disease vaccine that prevents B. burgdorferi infection in dogs
|
Marconi, Richard T.
|
|
|
6 |
C |
p.
|
article
|
| 9 |
What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?
|
Hellerstein, Marc
|
|
|
6 |
C |
p.
|
article
|
Journal description